Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis
Objectives Evaluation of remdesivir, an RNA polymerase inhibitor, for effectiveness in adults with COVID-19.Data sources Electronic search for eligible articles of PubMed, Cochrane Central and clinicaltrials.gov was performed on 20 September 2020.Participants and study eligibility criteria Only rand...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-06-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/11/6/e048416.full |